Advertisement
Advertisement
RPID
Rapid Micro Biosystems, Inc. Class A Common Stock
2.13
USDSponsored
0.00
+0.24%
Apr 10, 15:51 UTC -4
Closed
After-Market
2.12
0.00
-0.24%
RPID Earnings Reports
Positive Surprise Ratio
RPID beat 8 of 19 last estimates.
42%
Next Report
Date of Next Report
May 07, 2026
Estimate for Q1 26 (Revenue/ EPS)
$7.75M
/-$0.25
Implied change from Q4 25 (Revenue/ EPS)
-31.29%
/-10.71%
Implied change from Q1 25 (Revenue/ EPS)
+7.59%
/-3.85%
Rapid Micro Biosystems, Inc. Class A Common Stock earnings per share and revenue
On Mar 12, 2026, RPID reported earnings of -0.28 USD per share (EPS) for Q4 25, missing the estimate of -0.22 USD, resulting in a -23.35% surprise. Revenue reached 11.28 million, compared to an expected 11.58 million, with a -2.55% difference. The market reacted with a +21.05% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 analysts forecast an EPS of -0.25 USD, with revenue projected to reach 7.75 million USD, implying an decrease of -10.71% EPS, and decrease of -31.29% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AngioDynamics, Inc.
Report Date
Apr 02, 2026 For Q3 26
Estimate
-$0.11
Actual
$0.02
Surprise
+117.83%
LENSAR, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.07
Actual
-$0.12
Surprise
-68.07%
Xtant Medical Holdings, Inc.
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.00
Actual
$0.00
Surprise
+100.00%
Adagio Medical Holdings, Inc Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$0.31
Actual
-$0.16
Surprise
+49.40%
PAVmed Inc. Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$5.50
Actual
-$5.52
Surprise
-0.22%
American Shared Hospital Services
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.02
Actual
-$0.09
Surprise
-545.54%
NexGel, Inc Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.12
Surprise
-30.72%
ENDRA Life Sciences Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$1.25
Actual
-$3.26
Surprise
-159.84%
FAQ
What were Rapid Micro Biosystems, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Rapid Micro Biosystems, Inc. Class A Common Stock reported EPS of -$0.28, missing estimates by -23.35%, and revenue of $11.28M, -2.55% below expectations.
How did the market react to Rapid Micro Biosystems, Inc. Class A Common Stock's Q4 2025 earnings?
The stock price moved up 21.05%, changed from $3.04 before the earnings release to $3.68 the day after.
When is Rapid Micro Biosystems, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for May 07, 2026.
What are the forecasts for Rapid Micro Biosystems, Inc. Class A Common Stock's next earnings report?
Based on 3
analysts, Rapid Micro Biosystems, Inc. Class A Common Stock is expected to report EPS of -$0.25 and revenue of $7.75M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement